Results 271 to 280 of about 126,285 (384)

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.

Addiction, 2014
Y. Hser, A. Saxon, David Y. C. Huang, A. Hasson, Christie Thomas, M. Hillhouse, Petra Jacobs, Cheryl Teruya, P. McLaughlin, K. Wiest, Allan J. Cohen, W. Ling   +11 more
semanticscholar   +1 more source

National consensus statement on opioid agonist treatment in custodial settings

Medical Journal of Australia, Volume 222, Issue 5, Page 262-268, March 2025.
Abstract Introduction Opioid use and dependence are prevalent among incarcerated people, contributing to elevated rates of overdose and other harms in this population. Opioid agonist treatment (OAT) has been shown to be an effective intervention to mitigate these risks. However, challenges to health care implementation in the custodial sector result in
Jocelyn Chan, Jon Cook, Michael Curtis, Adrian J Dunlop, Ele Morrison, Suzanne Nielsen, Rebecca J Winter, Thileepan Naren   +7 more
wiley   +1 more source

Does a take-home dose program result in better patient adherence to methadone? Evidence from Vietnam. [PDF]

Harm Reduct J
Nong T, Hodgkin D, Diep NB, Capoccia V, Horgan C, Canh HD, Le G.   +6 more
europepmc   +1 more source

Consolidation, Systematic Appraisal and Comparison of Guideline Recommendations Regarding Management of Chronic Pain: Protocol for a Digital Chronic Pain Recommendation Map

Clinical and Public Health Guidelines, Volume 2, Issue 4, October 2025.
ABSTRACT Introduction Chronic pain affects 1 in 5 adults and children globally; however, management remains highly variable and low value care is common. Inconsistent recommendations among clinical practice guidelines for management of chronic pain contribute to suboptimal patient management.
Andrea J. Darzi, Kian Torabiardakani, Gonzalo Bravo‐Soto, Daniela Montalva‐Romero, Rachel J. Couban, Lynn Cooper, Stacey Ritz, Jaris Swidrovich, Ivan D. Florez, Vivian Welch, Gordon H. Guyatt, Holger J. Schünemann, Jason W. Busse, on behalf of the Chronic Pain RecMap Collaborative, Ahmad Firas Khalid, Abhimanyu Sud, Alfonso Iorio, Anaïs Lacasse, Andrew Thomas, Artur Nowak, Bart Dietl, Behnam Sadeghirad, Cyd Courchesne, Dena Zeraatkar, Edoardo Aromataris, Elaine Harrow, Farid Foroutan, Fei Yutong, Gabriel Rada, Glen Hazlewood, Hugo Massé‐Alarie, Jennifer Petkovic, Justyna Litynska, Keven Phinney, Lawrence Mbuagbaw, Li Wang, Lisa Graves, Luc J. Hébert, Marc‐André Blanchette, Peter Tugwell, Rebecca Morgan, Jean‐Sebastien Roy, Thomas Piggott, Trevor Jenvenne, Yaolong Chen, Ying Zhang, Zachary Munn, Zoe Jordan, Rana Yamout   +48 more
wiley   +1 more source

Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single arm clinical trial. [PDF]

Addict Sci Clin Pract
Azar P, Ignaszewski MJ, Harris M, Barazanci Z, Davison R, Wong JSH, Maharaj A, Mathew N, Hall D, Guillemi SA, Foreman J, Barrios R, Montaner JSG.   +12 more
europepmc   +1 more source

Health Promotion Opportunities for Lesbian, Gay and Bisexual People: Using Data From the New Zealand Health Survey

Health Promotion Journal of Australia, Volume 36, Issue 4, October 2025.
ABSTRACT Issue Addressed Health inequity for sexual minority (lesbian, gay and bisexual) people compared with heterosexual people is well documented globally. However, limited local data have been used to inform health policy and practice. This project analysed data from the New Zealand Health Survey to determine areas of inequity in health behaviours ...
Jeffery Adams, Jintana Jankhotkaew, Sonja J. Ellis, Stephen Neville   +3 more
wiley   +1 more source

Comparative effectiveness of missed dose protocols of opioid agonist treatment in British Columbia, Canada: protocol for a population-based target trial emulation. [PDF]

BMJ Open
Mondol MH, Min JE, Kurz M, Zanette M, Hossain MB, Bach P, Gustafson P, Platt RW, Seaman S, Socías ME, Nosyk B, Karim ME.   +11 more
europepmc   +1 more source

Thoracotomy without opioids in a heroin addict maintained with oral methadone

, 1998
G. S. Voyagis, V. Dimitriou, M. SEMEOPHORIDOU, A. Tragou   +3 more
openalex   +1 more source

Biallelic FGF4 Variants Linked to Thoracic Dystrophy and Respiratory Insufficiency

Clinical Genetics, Volume 108, Issue 4, Page 479-485, October 2025.
We report three people from two unrelated families with a clinical diagnosis of thoracic dystrophy characterized by short or missing ribs, narrow chest, and respiratory insufficiency. Affected people each have rare, biallelic, predicted deleterious missense substitutions in FGF4, a gene known to be essential for the formation of the thoracic skeleton ...
Laura M. Watts, Esther Kinning, Donald R. Latner, Marla Johnston, Jessica Patrick‐Esteve, Gregory M. Cooper, Stephen R. F. Twigg, Alistair T. Pagnamenta, Jenny C. Taylor   +8 more
wiley   +1 more source

Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, Canada. [PDF]

BMJ Open
Yan R, Hossain MB, Min JE, Kurz M, Smith K, Piske M, Seaman S, Bach P, Karim E, Platt RW, Siebert U, Socías ME, Xie H, Nosyk B.   +13 more
europepmc   +1 more source